Difference between revisions of "Pituitary gland"

Jump to navigation Jump to search
186 bytes added ,  10:24, 30 September 2022
(→‎Pituitary adenoma: Starting Update on 2022 WHO classification)
Line 162: Line 162:
! Transcription factor
! Transcription factor
|-
|-
|
| Somatotroph adenoma
| Densely and sparsely granulated adenoma, Mammosomatotroph adenoma, Mixed GH and PRL adenoma
| GH +/- PRL
| PIT1
| PIT1
| Somatotroph tumor
| Densely and sparsely granulated tumor
| GH, a-subunit+/-, CK+
| PIT1
|-
| PIT1
| Lactotroph tumor
| Densely and sparsely granulated tumor
| PRL, CK-ve or weak
| PIT1, [[Estrogen receptor|ER]]
|-
|-
|
| PIT1
| Lactotroph adenoma
| Mammosomatotroph tumor
| Densely and sparsely granulated adenoma, Acidophilic stem cell adenoma
|  
| PRL
| GH, PRL (usu. less), CK perinuclear +ve
| PIT1, [[Estrogen receptor|ER]]
| PIT1, [[Estrogen receptor|ER]]
|-
|-
| PIT1
| Thyrotroph tumor
|
|
| Thyrotroph adenoma
| TSH, CK-ve or weak
|
| PIT1, GATA3
| TSH
|-
| PIT1, [[Estrogen receptor|ER]]
| PIT1
| Mature plurihormonal PIT1 lineage tumor
|
| GH, PRL, TSH, a-subunit +/-ve
| PIT1, [[Estrogen receptor|ER]], GATA3
 
|-
|-
|
|
Account-creators
1,040

edits

Navigation menu